Den europeiske union - norsk - EMA (European Medicines Agency)

janssen-cilag international nv - ciltacabtagene autoleucel - multippelt myelom - carvykti is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.

Den europeiske union - norsk - EMA (European Medicines Agency)

gsk vaccines s.r.l. - ytre membran blemmer fra neisseria meningitidis gruppe b (belastning nz 98/254), rekombinant neisseria meningitidis gruppe b fhbp fusion protein, rekombinant neisseria meningitidis gruppe b nada protein, rekombinant neisseria meningitidis gruppe b nhba fusion protein - meningitt, meningokokk - meningokokker-vaksiner - aktiv immunisering mot invasiv sykdom forårsaket av neisseria meningitidis serogruppe-b-stammer.

Norge - norsk - Statens legemiddelverk

sanofi-aventis norge (3) - hydrokortison / cinkokainhydroklorid / framycetinsulfat / eskulin - rektalsalve - 5 mg / 5 mg / 10 mg / 10 mg

Norge - norsk - Statens legemiddelverk

pensa pharma ab - esomeprazolnatrium - enterokapsel, hard - 40 mg

Norge - norsk - Statens legemiddelverk

pensa pharma ab - esomeprazolnatrium - enterokapsel, hard - 20 mg

Norge - norsk - Statens legemiddelverk

sandoz - københavn - esomeprazolmagnesiumtrihydrat - enterotablett - 40 mg

Norge - norsk - Statens legemiddelverk

sandoz a/s - esomeprazolmagnesiumtrihydrat - enterotablett - 20 mg

Norge - norsk - Statens legemiddelverk

cheplapharm arzneimittel gmbh - omeprazolmagnesium - enterotablett - 10 mg

Norge - norsk - Statens legemiddelverk

cheplapharm arzneimittel gmbh - omeprazolmagnesium - enterotablett - 20 mg

Norge - norsk - Statens legemiddelverk

bluefish pharmaceuticals ab - omeprazol - enterokapsel, hard - 20 mg